The continuum model of selection in human tumors: General paradigm or niche product?

Cancer Research

Volumn 72, Issue 13, 2012, Pages 3131-3134

  Leedham, Simon ^a   Tomlinson, Ian ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; GENE; GENE MUTATION; GENETIC MODEL; GENETIC PREDISPOSITION; HUMAN; ONCOGENE; PRIORITY JOURNAL; PTEN GENE; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

ANIMALS; HUMANS; MICE; MICE, MUTANT STRAINS; MODELS, GENETIC; NEOPLASMS;

EID: 84863595550     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1052     Document Type: Short Survey

References (13)

1. Johannsen W. The genotype conception of heredity. Amer Nat 1911;45:129-59.
2. Sieber OM, Tomlinson SR, Tomlinson I. Tissue, cell and stage specificity of (epi)mutations in cancers. Nat Rev Cancer 2005;5:649-55. (Pubitemid 41081390)
3. Berger AH, Knudson AG, Pandolfi PP. A continuum model for tumour suppression. Nature 2011;476:163-9.
4. Jones DD. Oncogene theory. Science 1974;184:853.
5. Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci U S A 1993;90:10914-21. (Pubitemid 23354339)
6. Blagosklonny MV. p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect. FASEB J 2000;14:1901-7.
7. Santarosa M, Ashworth A. Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim Biophys Acta 2004;1654:105-22. (Pubitemid 38681204)
8. Greenman C, Wooster R, Futreal PA, Stratton MR, Easton DF. Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 2006;173:2187-98. (Pubitemid 44285695)
9. Varghese JS, Easton DF. Genome-wide association studies in common cancers-what have we learnt? Curr Opin Genet Dev 2010;20:201-9.
10. Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJ, et al. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 2002;11:1549-60. (Pubitemid 34679255)
11. Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, Bell J, et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med 1999;5:1071-5. (Pubitemid 29439582)
12. Albuquerque C, Baltazar C, Filipe B, Penha F, Pereira T, Smits R, et al. Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosomes Cancer 2010;49:746-59.
13. Leedham SJ, Rodenas-Cuadrado P, Howarth K, Lewis A, Mallappa S, Segditsas S, et al. A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts. Gut 2012 Jan 27. [Epub ahead of print].